Wednesday, February 10, 2010, 2:19PM AEST - The Australian Stockmarket closes in 1 hour and 46 minutes.
To create a watchlist or portfolio of shares, Register

QLT Inc. (QLTI)

 8:00AM AEST: 4.48 USD  Down 0.03 (0.67%)  
 MORE ON QLTI 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 QLT Inc. (NasdaqNM:QLTI) Delayed quote dataEdit
Last Trade:4.48 USD
Trade Time: 8:00AM AEST
Change:Down 0.03 (0.67%)
Prev Close:4.51
Open:4.54
Bid:N/A
Ask:5.16 x 300
1y Target Est:4.87
Day's Range:4.48 - 4.56
52wk Range:1.40 - 5.15
Volume:67,253
Avg Vol (3m):333,827
Market Cap:244.74M
P/E (ttm):11.12
EPS (ttm):0.40
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add QLTI to Portfolio   Download Data

 HEADLINES 
•Cash Rich, No Debt Stocks
at Investopedia (Tue 5:58AM)
•QLT's Attractive Risk/Reward Profile
at Seeking Alpha (Fri, Jan 29)
•QLT Inc. Earnings Call scheduled for Wed, Mar 10
CCBN (Fri, Jan 22)
•QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 31)
•QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million
GlobeNewswire (Thu, Dec 31)
•5 Value Stocks Worth Considering
at Seeking Alpha (Thu, Dec 24)
•QLT Inc. establishes sales force in the United States
PR Newswire (Tue, Dec 22)
•Prospecting for Stocks: QLT
at Motley Fool (Thu, Dec 17)
•QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Dec 15)
•QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis
PR Newswire (Tue, Dec 15)
•QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Dec 9)
•6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy
CNW Group (Wed, Dec 9)
More Headlines for QLTI...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.34
EPS Est (in 2 years) (Dec-10) :-0.07
Avg Rec (current)*:2.7
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
QLT Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of pharmaceutical products, primarily in the field of ophthalmology.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices